Post Intensive Care Unit Atrial Fibrillation
Recruiting · NCT05860894 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Universitaire de Besancon
View the official record on ClinicalTrials.gov →Interventions studied
Implantable ECG holter device (Biomonitor3, Biotronik)
What this trial is about
Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age \>18 years
- New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds)
- Patient hospitalized in the ICU with at least one of the following two criteria:
- orotracheal intubation for mechanical ventilation
- AND/OR treatment with amines (vasopressors or inotropic agents)
- Written informed consent
- Patient affiliated to a social security regime (or beneficiary thereof)
Exclusion criteria
- Documented history of atrial fibrillation
- patients admitted to the ICU after cardiothoracic surgery
- Patients with life expectancy \<12 months
- Patients under legal or judicial protection
- Patients with no social security coverage
- Patients within the exclusion period of another clinical trial
Where it is running
1 location listed.
- Centre Hospitalier Universitaire de Besancon - Besançon, France